PHARMACY & PHARMACOLOGY (PHARM) -> PHARM - Mechanical Circulatory Support Abstracts

206 - Impact of Aspirin Dosing on Thrombotic Outcomes in Patients with the HVAD™

Presentation Number
206
Speakers
Session Name
SESSION 56 - ORAL: The Pharmacist is IN! LVAD, Heart, and Lung Transplant Medication Questions Answered
Date
Fri, Apr 24, 2020
Time
10:30 AM - 12:15 PM
Authors
Audio Upload

Previous ePresentation
205 - Aspirin Sensitivity Wanes Early during Left Ventricular Assist Device Support

Next ePresentations
210 - An Exclusively Oral Ribavirin Regimen for Respiratory Syncytial Virus Infection after Lung Transplantation is Effective and Cost-Efficient
213 - Long-Term Neurocognitive Outcomes in LVAD Recipients
217 - Outflow Graft Obstruction Causing Recurrent Heart Failure after Left Ventricular Assist Device Implantation
223 - Blood Transfusion Requirements for Patients on Extracorporeal Membrane Oxygenation
242 - Contemporary Sex-Based Outcomes after Orthotopic Heart Transplantation for Patients Bridged with Newer Generation Left Ventricular Assist Devices
245 - Waitlist Outcomes in Patients with Blood Group O during Continuous Flow Left Ventricular Assist Device Support
246 - Association of Cardiac Rehabilitation with Improved Healthcare Utilization and Long-Term Survival after Left Ventricular Assist Device Implantation
250 - Extended Post EVLP Cold Preservation Increases Risk of Primary Graft Dysfunction and Mortality
254 - Proteomics Analysis of Circulating Extracellular Vesicles Isolated from Plasma of Human Lung Transplant Recipients
256 - Circulating Exosomes from Human Lung Transplant Recipients Having Respiratory Viral Infections Contain Nucleic Acids and Activate Signaling Pathways CGAS/STING and RIG-1